PLU-1/JARID1B overexpression predicts proliferation properties in head and neck squamous cell carcinoma

Oncology Reports
Zhibin CuiLi Mao

Abstract

PLU-1/JARID1B (jumonji AT rich interactive domain 1B) is one of the testis cancer antigens and functions as a histone demethylase in the regulation of various human types of cancers. However, its functions in head and neck squamous cell carcinoma (HNSCC) are rarely reported. The aim of the present study was to examine PLU-1/JARID1B expression levels in HNSCCs and to investigate its role in cancer cell proliferation. In the present study, we found that PLU-1/JARID1B mRNA was upregulated in all tested HNSCC cell lines. Immunohistochemical staining showed that PLU-1/JARID1B protein expression was detected in 87.8% (87/99) of the HNSCC cases. A positive association was observed between high PLU-1/JARID1B expression and higher Ki-67 labeling in the HNSCC samples (Pearson r=0.6514, P=0.0003). Stable PLU-1/JARID1B knockdown by PLU-1-shRNAs in the HNSCC cell lines suppressed cell growth both in the in vitro and in vivo studies. Moreover, PLU-1/JARID1B knockdown resulted in G1 arrest and early apoptosis by suppressing Bcl-2 family members in the HNSCCs. These data indicate that PLU-1/JARID1B is overexpressed in HNSCCs and is associated with tumor proliferation and apoptosis. Therefore, PLU-1/JARID1B represents a candidate proliferation ...Continue Reading

References

Jun 1, 1990·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·D Oda, E Watson
Jul 27, 1999·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·P C ClahsenM J van de Vijver
Sep 19, 2002·International Journal of Cancer. Journal International Du Cancer·Angela BarrettJoyce Taylor-Papadimitriou
Jun 28, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ColozzaM J Piccart
Mar 22, 2007·International Journal of Cancer. Journal International Du Cancer·Angela BarrettJoyce Taylor-Papadimitriou
Nov 26, 2010·International Journal of Cancer. Journal International Du Cancer·Julia A ColemanJoyce Taylor-Papadimitriou
Oct 25, 2011·The EMBO Journal·Sandra U SchmitzKristian Helin
Nov 25, 2011·Methods in Molecular Biology·Leanne Stalker, Christopher Wynder
Jun 20, 2012·Nature Reviews. Urology·Prakash KulkarniRobert H Getzenberg
Dec 19, 2012·The International Journal of Biochemistry & Cell Biology·Qiang SunWantao Chen
Jan 5, 2013·British Journal of Cancer·P V JitheshR J Shaw
Jan 29, 2013·International Journal of Oncology·Katsuya OhtaHideshi Ishii
May 21, 2013·Biochimica Et Biophysica Acta·Stefano AmenteBarbara Majello

❮ Previous
Next ❯

Citations

Dec 16, 2016·Oncotarget·Mengjiao HanXian Wang
Oct 22, 2018·European Journal of Medicinal Chemistry·Yi-Chao ZhengHong-Min Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Acta otorrinolaringológica española
Juan Pablo Rodrigo TapiaMaría Pilar Fernández
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Akira NoguchiYasuo Takano
Archives of Otolaryngology--head & Neck Surgery
Chad A GlazerJoseph A Califano
© 2021 Meta ULC. All rights reserved